Biomarkers of Stroke: Its Utility in Routine Clinical Practice
- PMID: 35694063
- PMCID: PMC9187415
- DOI: 10.1055/s-0042-1744229
Biomarkers of Stroke: Its Utility in Routine Clinical Practice
Conflict of interest statement
Conflict of Interest None declared.
References
-
- Biomarkers Definitions Working Group. . Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(03):89–95. - PubMed
-
- Powers W J, Rabinstein A A, Ackerson T. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–e418. - PubMed
-
- Michetti F, Corvino V, Geloso M C. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J Neurochem. 2012;120(05):644–659. - PubMed
-
- Isgrò M A, Bottoni P, Scatena R. Neuron-specific enolase as a biomarker: biochemical and clinical aspects. Adv Exp Med Biol. 2015;867:125–143. - PubMed
